The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $131.54

Today's change+1.10 +0.84%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $131.54

Today's change+1.10 +0.84%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc up (U.S.)$1.10

Alexion Pharmaceuticals Inc closed up Friday by (U.S.)$1.10 or 0.84% to (U.S.)$131.54. Over the last five days, shares have gained 2.11% and 7.51% year to date. Shares have underperformed the S&P 500 by 30.02% during the last year.

Key company metrics

  • Open(U.S.) $131.37
  • Previous close(U.S.) $130.44
  • High(U.S.) $132.46
  • Low(U.S.) $130.00
  • Bid / Ask(U.S.) $110.58 / (U.S.) $135.12
  • YTD % change+7.51%
  • Volume1,657,255
  • Average volume (10-day)2,587,729
  • Average volume (1-month)2,215,518
  • Average volume (3-month)2,861,500
  • 52-week range(U.S.) $109.12 to (U.S.) $162.00
  • Beta1.35
  • Trailing P/E74.75×
  • P/E 1 year forward25.07×
  • Forward PEG1.34×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.76
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX1.57%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue831799753701
Total other revenue--------
Total revenue831799753701
Gross profit763728692642
Total cost of revenue67716159
Total operating expense704620558535
Selling / general / administrative260230232233
Research & development206196179167
Depreciation / amortization80828089
Interest expense (income), net operating--------
Unusual expense (income)91417-13
Other operating expenses, total--------
Operating income127179195166
Interest income (expense), net non-operating-25-----24
Gain (loss) on sale of assets--------
Other--------
Income before tax104158170144
Income after tax929411592
Income tax, total12645551
Net income929411592
Total adjustments to net income--------
Net income before extra. items929411592
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items929411592
Inc. avail. to common incl. extra. items929411592
Diluted net income929411592
Dilution adjustment--------
Diluted weighted average shares228226226227
Diluted EPS excluding extraordinary itemsvalue per share0.400.420.510.41
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.760.530.530.37